Swiss National Bank - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$7,630,296
-15.1%
480,800
+1.0%
0.01%0.0%
Q2 2023$8,984,007
+445.6%
476,100
+11.0%
0.01%
+500.0%
Q1 2023$1,646,592
-30.8%
428,800
-10.6%
0.00%
-50.0%
Q4 2022$2,378,816
+5.7%
479,600
+1.9%
0.00%0.0%
Q3 2022$2,250,000
+6.9%
470,700
+0.7%
0.00%
+100.0%
Q2 2022$2,104,000
-7.8%
467,500
-2.4%
0.00%0.0%
Q1 2022$2,281,000
-31.0%
479,100
+7.6%
0.00%
-50.0%
Q4 2021$3,304,000
+31.9%
445,300
+0.8%
0.00%0.0%
Q3 2021$2,505,000
-11.3%
441,800
+3.1%
0.00%0.0%
Q2 2021$2,823,000
-18.6%
428,4000.0%0.00%0.0%
Q1 2021$3,470,000
+36.1%
428,400
+8.4%
0.00%0.0%
Q4 2020$2,550,000
+79.2%
395,3000.0%0.00%
+100.0%
Q3 2020$1,423,000
-20.0%
395,300
+2.3%
0.00%
-50.0%
Q2 2020$1,778,000
+57.2%
386,600
+16.6%
0.00%
+100.0%
Q1 2020$1,131,000
-22.8%
331,700
+15.6%
0.00%
-50.0%
Q4 2019$1,465,000
+115.8%
286,900
+2.2%
0.00%
+100.0%
Q3 2019$679,000
+15.1%
280,600
+3.3%
0.00%0.0%
Q2 2019$590,000
-19.8%
271,7000.0%0.00%0.0%
Q1 2019$736,000
-41.8%
271,700
+3.1%
0.00%
-50.0%
Q4 2018$1,265,000
-47.4%
263,500
+3.7%
0.00%
-33.3%
Q3 2018$2,405,000
-2.7%
254,0000.0%0.00%0.0%
Q2 2018$2,471,000
+7.4%
254,000
+16.2%
0.00%0.0%
Q1 2018$2,300,000
+122.7%
218,600
+35.6%
0.00%
+200.0%
Q4 2017$1,033,000
-2.3%
161,200
+16.6%
0.00%0.0%
Q3 2017$1,057,000
+7.5%
138,2000.0%0.00%0.0%
Q2 2017$983,000
+59.3%
138,200
-13.3%
0.00%0.0%
Q1 2017$617,000
+89.8%
159,4000.0%0.00%0.0%
Q4 2016$325,000
-23.9%
159,4000.0%0.00%0.0%
Q3 2016$427,000
-13.0%
159,4000.0%0.00%0.0%
Q2 2016$491,000
-61.9%
159,400
+2.1%
0.00%
-50.0%
Q1 2016$1,289,000
-26.8%
156,100
+20.4%
0.00%
-50.0%
Q4 2015$1,760,000
+41.4%
129,7000.0%0.00%
+33.3%
Q3 2015$1,245,000
-24.9%
129,700
+12.6%
0.00%
-25.0%
Q2 2015$1,657,000
+51.5%
115,200
-5.7%
0.00%
+33.3%
Q1 2015$1,094,000
+86.4%
122,200
+27.0%
0.00%
+50.0%
Q4 2014$587,000
-41.2%
96,200
+2.1%
0.00%
-50.0%
Q3 2014$998,000
-12.1%
94,200
-1.7%
0.00%0.0%
Q2 2014$1,135,000
-20.6%
95,8000.0%0.00%
-33.3%
Q1 2014$1,430,000
+32.3%
95,800
+30.0%
0.01%
+50.0%
Q4 2013$1,081,000
-13.8%
73,7000.0%0.00%
-20.0%
Q3 2013$1,254,000
-2.5%
73,700
-4.9%
0.01%
-16.7%
Q2 2013$1,286,00077,5000.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders